ALBUQUERQUE, N.M. (KRQE) – Presbyterian is now offering monoclonal antibody therapy for COVID-19 patients. The treatment is only available for those ages 12 and older who are at high risk of COVID hospitalization.

Story continues below



Treatment should be started within 10 days of symptoms and a positive COVID test. A full list of requirements to receive the treatment is available online.